Results 41 to 50 of about 1,915,591 (341)

Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review

Italian Journal of Pediatrics, 2020
Background and objectives The goal of this literature review is to compare current studies regarding the accuracy of different serum markers in differentiating viral from bacterial pneumonia in the pediatric population with what is employed in the ...
Jithin Thomas, Aiste Pociute, R. Kėvalas, M. Malinauskas, Lina Jankauskaitė   +4 more
semanticscholar   +1 more source

Prevalence, Risk Factors, and Strain Distribution of Group A Streptococcus Carriage Among Indigenous Children in the Southwest United States

Proceedings
Background [...]
Catherine G. Sutcliffe, Victoria M. Sergent, Joyselynn Pitalua, Sopio Chochua, Christopher J. Gregory, Chloe Hurley, Zhongya Li, Saundra Mathis, Lesley McGee, Jennifer Onukwube Okaro, Theresa Tran, Robert Weatherholtz, Laura L. Hammitt   +12 more
doaj   +1 more source

C-reactive Protein Versus Neutrophil/lymphocyte Ratio in Differentiating Bacterial and Non-bacterial Pneumonia in Children

Journal of Nepal Health Research Council, 2017
Background: Pneumonia is a leading cause of childhood mortality in a low resource country. Simple laboratory markers can help differentiate between bacterial and non-bacterial pneumonias for appropriate management.
Eva Gauchan, Sudhir Adhikari
doaj   +1 more source

A pan-immune panorama of bacterial pneumonia revealed by a large-scale single-cell transcriptome atlas

Signal Transduction and Targeted Therapy
Bacterial pneumonia is a significant public health burden, contributing to substantial morbidity, mortality, and healthcare costs. Current therapeutic strategies beyond antibiotics and adjuvant therapies are limited, highlighting the need for a deeper ...
Kun Xiao, Yan Cao, Zhihai Han, Yuxiang Zhang, L. Luu, Liang Chen, Peng Yan, Wei Chen, Jiaxing Wang, Ying Liang, Xin Shi, Xiuli Wang, Fan Wang, Ye Hu, Zhengjun Wen, Yong Chen, Yuwei Yang, Haotian Yu, Lixin Xie, Yi Wang   +19 more
semanticscholar   +1 more source

Community-acquired bacterial pneumonia in adults: An update

The Indian journal of medical research, 2020
Community-acquired pneumonia (CAP) is the prominent cause of mortality and morbidity with important clinical impact across the globe. India accounts for 23 per cent of global pneumonia burden with case fatality rates between 14 and 30 per cent, and ...
V. Eshwara, C. Mukhopadhyay, J. Rello
semanticscholar   +1 more source

Incidence of Invasive Group A Streptococcal Infections and Comparison of emm Types from Carriage, Pharyngitis, and Invasive Infections in Indigenous Communities in the Southwest United States

Proceedings
Background: Indigenous communities are disproportionately affected by group A Streptococcus (GAS) infections [...]
Catherine G. Sutcliffe, Victoria M. Sergent, Joyselynn Pitalua, Sopio Chochua, Christopher J. Gregory, Chloe Hurley, Zhongya Li, Saundra Mathis, Lesley McGee, Jennifer Onukwube Okaro, Theresa Tran, Robert Weatherholtz, Laura L. Hammitt   +12 more
doaj   +1 more source

ANTIBIOTIC STEWARDSHIP STRATEGIES TO LIMIT INAPPROPRIATE ANTIBIOTIC USE AND REDUCE MULTI-DRUG RESISTANT PATHOGENS DURING COVID-19 PANDEMIC

International Journal of Infectious Diseases, 2023
Antibiotics have been extensively used in COVID-19 patients without a clear indication. COVID-19 pneumonia is associated with a mortality up to 20% varying by country with the number of global deaths over 5 million. Antibiotics have been extensively used
Anucha Apisarnthanarak
doaj   +1 more source

Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19

Cleveland Clinic journal of medicine, 2020
In COVID-19, respiratory infection with SARS-CoV-2 plus another virus (viral co-infection) or with SARS-CoV-2 plus a bacterial pathogen (combined viral and bacterial pneumonia) has been described.
Chao-ping Wu, Fatima Adhi, K. Highland
semanticscholar   +1 more source

Comparison of Short- versus Long-Course Antimicrobial Therapy of Uncomplicated Bacterial Pneumonia in Dogs: A Double-Blinded, Placebo-Controlled Pilot Study

Animals, 2021
Current treatment for canine bacterial pneumonia relies on protracted courses of antimicrobials (3–6 weeks or more) with recommendations to continue for 1–2 weeks past resolution of all clinical and thoracic radiographic abnormalities. However, in humans,
Aida I. Vientós-Plotts, Isabelle Masseau, Carol R. Reinero   +2 more
doaj   +1 more source

Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia

Journal of Clinical Medicine, 2020
Septicaemia likely results in high case-fatality rates in the present multidrug-resistant (MDR) era. Amongst them are hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), two frequent fatal septicaemic entities amongst ...
S. Jean, Yin-Chun Chang, Wei-Cheng Lin, Wen-Sen Lee, P. Hsueh, Chin-Wan Hsu   +5 more
semanticscholar   +1 more source